By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    physical health
    5 Ways Playing Games Can Improve Neural and Physical Health
    September 9, 2022
    Reasons For Hair Loss and Its Treatment
    Reasons For Hair Loss and Its Treatment
    February 16, 2022
    healthcare organization
    5 Actionable Strategies For Healthcare Organizations
    August 15, 2022
    Latest News
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Almost Anybody Qualifies for Medicaid in Maine
    November 23, 2012
    ebola and EHR
    Ebola: Are We Relying on EHR to Tell the Story?
    October 24, 2014
    Caitlin Kelly
    How Would You Fix Healthcare? – Question and Answers.
    January 16, 2013
    Latest News
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 22, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 22, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 22, 2025
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: MIGS Device Approval Brings Hope For Glaucoma Patients
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > MIGS Device Approval Brings Hope For Glaucoma Patients
Medical DevicesMedical InnovationsTechnology

MIGS Device Approval Brings Hope For Glaucoma Patients

Satyajit Shinde
Satyajit Shinde
Share
6 Min Read
MIGS-devices-market
SHARE

 

The U.S. FDA has already approved Ivantis’s Hydrus Microstent and Allergan’s XEN Gel Stent for minimally invasive glaucoma surgery. With ongoing research activities, there will be more approvals in the future to help glaucoma patients.

The World Health Organization (WHO) survey states that glaucoma is the second highest cause of blindness in the world. Many people have this condition, but unaware of it. The symptoms are not evident until the patient loses his sight. Judith Smith, a nurse by profession, showed the signs of glaucoma during her regular visit to the ophthalmologist a few years ago. Even though glaucoma is a permanent condition, the available treatment can slow down the progression. There are eye drops available which can either increase or decrease the quantity of fluid in the eye or enhance the outward flow. This reduces the eye pressure and safeguards the optic nerve from damage. However, some patients do not respond well to them and show negative effects. Smith was one of them.

Then she met Robert Feldman, M.D., Chair of the Ruiz Department of Ophthalmology and Visual Science at McGovern Medical School at UTHealth, at her workplace. He was conducting a clinical trial to determine the efficacy of a minimally-invasive glaucoma surgery that used the InnFocus MicroShunt Glaucoma Drainage System. The study also aimed to compare the new system with a traditional trabeculectomy. Smith participated in the study.

More Read

Image
Health Startups that Interest @HealthCursor @medmocha
The DNA Doctor Consultation Of the Future
Healthcare Technology and the DocResponse Revolution – Meet Your New Best Friend in Healthcare
Hexoskin: A Second Skin for the Quantified Athlete and Maybe Even You!
Finding A Cure For Alopecia: How Close Are We?

The procedure in the study involved creating a small incision in the eye through which a MicroShunt will be inserted. This MicroShunt is the twice the size of an eyelash. It allows fluid to drain from the anterior chamber to the conjunctival flap of the eye. Researchers have used this procedure on 30 times during the past three years. Many of the participants have shown great outcomes. This procedure reduces recovery time and eliminates the need for surgery. The InnFocus MicroShunt procedure slows down the progression of glaucoma.

There have been many trials performed by research institutes and organizations to find minimally invasive devices for glaucoma surgery. The U.S. Food and Drug Administration (FDA) approved many of the stents for treatment of patients with glaucoma. Ivantis, a company aimed for development of innovative solutions for glaucoma, received FDA approval for Hydrus® Microstent. It is a minimally invasive glaucoma surgery (MIGS) device that can be utilized for the treatment of mild to moderate open-angle glaucoma in collaboration with cataract surgery.

David F. Chang, M.D., clinical professor of Ophthalmology at the University of California, San Francisco, said, “The Hydrus Microstent scaffolds approximately 90 degrees of the patient’s natural canal outflow pathway. Correct anatomic placement into the canal will also be easier for surgeons to confirm.”

The clinical data regarding Hydrus shows its safety and two-year efficacy along with its ability to eliminate medications. The eyelash-sized device lowers the eye pressure through maintenance of flow through Schlemm’s canal, the eye’s natural outflow pathway. It has been used in nearly 4,000 procedures across the globe. Ivantis is now planning to build the commercial and manufacturing infrastructures along with the launch of the product in late 2018.

In November 2016, the FDA also approved XEN Gel Stent by Allergan. This device can be used in MIGS procedures combined with cataract surgery to enable a two-in-one procedure. It will reduce IOP through drainage of aqueous humor into the subconjunctival space. It avoids the use of the traditional pathways such as the uveoscleral pathway or the trabecular meshwork.

The Xen Glaucoma Treatment System has the Xen 45 gel stent along with the disposable Xen injector. The 6 mm gel stent has gelatin cross-linked with glutaraldehyde, which is stiff but gets flexible when hydrated using the aqueous humor. This hydration makes the gel secure from erosion or fibrosis. The cross-linking prevents the degradation of the stent over time. These factors ensure a stable structure of the gel stent to circulate the aqueous humor appropriately. The stent is inserted through a corneal incision using the Xen injector. Then gel stent reduces IOP by letting the aqueous humor drain through the subconjunctival space. This is a minimally invasive approach.

The trend of FDA approval will continue with ongoing research and development activities, it will take the MIGS devices market to great heights. According to the research firm Allied Market Research, the global minimally invasive glaucoma surgery (MIGS) devices market would reach $912 million by 2023. Owing to long-term IOP control and the ability of clinicians to intervene in earlier stages of glaucoma lifecycle, the demand for MIGS devices is increasing. In a discussion with Primary Care Optometry News, John Berdahl, MD, said the benefits of micro-invasive glaucoma surgery (MIGS) have been overwhelming and offer safety. “Surgeons across the U.S. are flocking to these procedures,” he added. “With MIGS, we can lower eye pressure without patients having to take medication, or we can reduce the number of medications they need while still not subjecting them to the risks of traditional glaucoma surgery.”

TAGGED:glaucomamigs devicesmigs devices market
Share This Article
Facebook Copy Link Print
Share
By Satyajit Shinde
Follow:
Satyajit has always had a keen interest in reading and writing. He forayed into the field of writing due to his love for words and the urge to do something different. He aspires to make each of his written works a piece of art.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

engineer fitting prosthetic arm
How Social Security Disability Shapes Access to Care and Everyday Health
Health care
August 20, 2025
a woman explaining the document
How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
Public Health
August 20, 2025
physiotherapist at work
How One Fall Can Lead to a Long Road of Medical Complications
Health care
August 20, 2025
Common Healthcare Accreditation Programs
7 Most Common Healthcare Accreditation Programs: Which Should You Use?
Health News
August 20, 2025

You Might also Like

ListenLogic Health Patient Journey
eHealthMedical DevicesMedical EducationSocial MediaTechnologyWellness

Using Advanced Social Intelligence to Understand the Patient Journey

March 30, 2015
eHealthTechnology

Here’s The Real Truth About Online Medical Services

March 15, 2019
patient empowerment
BusinessHealth ReformMobile HealthNewsPolicy & LawTechnology

How Health Innovators Can Foster Patient Empowerment

May 7, 2014

The Value of Connectivity in Healthcare

June 19, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?